Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling

Abstract Approximately half of U.S. women giving birth annually receive Pitocin, a synthetic form of oxytocin (OXT), yet the optimal dosing remains challenging due to significant individual variability in response. To address this, we developed a mathematical model examining the effects of five OXT...

Full description

Saved in:
Bibliographic Details
Main Authors: Preeti Dubey, Yingye Fang, K. Lionel Tukei, Shobhan Kuila, Xinming Liu, Annika Sahota, Antonina I. Frolova, Erin L. Reinl, Manasi Malik, Sarah K. England, Princess I. Imoukhuede
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:npj Women's Health
Online Access:https://doi.org/10.1038/s44294-025-00058-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861500017639424
author Preeti Dubey
Yingye Fang
K. Lionel Tukei
Shobhan Kuila
Xinming Liu
Annika Sahota
Antonina I. Frolova
Erin L. Reinl
Manasi Malik
Sarah K. England
Princess I. Imoukhuede
author_facet Preeti Dubey
Yingye Fang
K. Lionel Tukei
Shobhan Kuila
Xinming Liu
Annika Sahota
Antonina I. Frolova
Erin L. Reinl
Manasi Malik
Sarah K. England
Princess I. Imoukhuede
author_sort Preeti Dubey
collection DOAJ
description Abstract Approximately half of U.S. women giving birth annually receive Pitocin, a synthetic form of oxytocin (OXT), yet the optimal dosing remains challenging due to significant individual variability in response. To address this, we developed a mathematical model examining the effects of five OXT receptor (OXTR) variants (V45L, P108A, L206V, V281M, and E339K) on OXT–OXTR binding dynamics in human embryonic kidney cells (HEK293T) and myometrial smooth muscle cells. The model was parameterized using experimentally derived, cell-specific OXTR surface localization measurements and literature-reported OXT-OXTR-binding kinetics. The model revealed differences in time to equilibrium between HEK293T and myometrial cells, distinct dynamics among genetic variants, and that early increases in OXT could partially rescue diminished responses in V281M and E339K variants. This model provides key insights into how genetic variants influence OXT dose responses and offers a framework for tailoring OXT dosing to patient-specific genetic profiles.
format Article
id doaj-art-c1a1adc5274c4c4290725da0a1a0d366
institution Kabale University
issn 2948-1716
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series npj Women's Health
spelling doaj-art-c1a1adc5274c4c4290725da0a1a0d3662025-02-09T13:00:34ZengNature Portfolionpj Women's Health2948-17162025-02-013111210.1038/s44294-025-00058-yPredicting oxytocin binding dynamics in receptor genetic variants through computational modelingPreeti Dubey0Yingye Fang1K. Lionel Tukei2Shobhan Kuila3Xinming Liu4Annika Sahota5Antonina I. Frolova6Erin L. Reinl7Manasi Malik8Sarah K. England9Princess I. Imoukhuede10Department of Biomedical Engineering, University of WashingtonDepartment of Biomedical Engineering, University of WashingtonDepartment of Biomedical Engineering, University of WashingtonDepartment of Biomedical Engineering, University of WashingtonDepartment of Biomedical Engineering, University of WashingtonDepartment of Biomedical Engineering, University of WashingtonCenter for Reproductive Health Sciences, Department of Obstetrics and Gynecology, WashU MedicineCenter for Reproductive Health Sciences, Department of Obstetrics and Gynecology, WashU MedicineCenter for Reproductive Health Sciences, Department of Obstetrics and Gynecology, WashU MedicineCenter for Reproductive Health Sciences, Department of Obstetrics and Gynecology, WashU MedicineDepartment of Biomedical Engineering, University of WashingtonAbstract Approximately half of U.S. women giving birth annually receive Pitocin, a synthetic form of oxytocin (OXT), yet the optimal dosing remains challenging due to significant individual variability in response. To address this, we developed a mathematical model examining the effects of five OXT receptor (OXTR) variants (V45L, P108A, L206V, V281M, and E339K) on OXT–OXTR binding dynamics in human embryonic kidney cells (HEK293T) and myometrial smooth muscle cells. The model was parameterized using experimentally derived, cell-specific OXTR surface localization measurements and literature-reported OXT-OXTR-binding kinetics. The model revealed differences in time to equilibrium between HEK293T and myometrial cells, distinct dynamics among genetic variants, and that early increases in OXT could partially rescue diminished responses in V281M and E339K variants. This model provides key insights into how genetic variants influence OXT dose responses and offers a framework for tailoring OXT dosing to patient-specific genetic profiles.https://doi.org/10.1038/s44294-025-00058-y
spellingShingle Preeti Dubey
Yingye Fang
K. Lionel Tukei
Shobhan Kuila
Xinming Liu
Annika Sahota
Antonina I. Frolova
Erin L. Reinl
Manasi Malik
Sarah K. England
Princess I. Imoukhuede
Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
npj Women's Health
title Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
title_full Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
title_fullStr Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
title_full_unstemmed Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
title_short Predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
title_sort predicting oxytocin binding dynamics in receptor genetic variants through computational modeling
url https://doi.org/10.1038/s44294-025-00058-y
work_keys_str_mv AT preetidubey predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT yingyefang predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT klioneltukei predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT shobhankuila predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT xinmingliu predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT annikasahota predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT antoninaifrolova predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT erinlreinl predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT manasimalik predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT sarahkengland predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling
AT princessiimoukhuede predictingoxytocinbindingdynamicsinreceptorgeneticvariantsthroughcomputationalmodeling